Global Drug R&D Express (Sep. 2023)

Based on data from the Synapse database, we recently published Global Innovative Drug Report, which offers a comprehensive overview of the latest advancements in the pharmaceutical industry and analysis of each selected drug, examining their snapshot, R&D status, active patents, mechanisms of action, clinical trials, competitive landscape, and other pertinent factors. The report consists of four parts:1.First Approved Drugs in September; 2. New Drug Analysis; 3.Global Drugs under Expedited Review Pathway in September; 4. Analysis of Selected ERP Drugs